Literature DB >> 25787243

Evidence of BRAF V600E in indeterminate cell tumor and interdigitating dendritic cell sarcoma.

Dennis P O'Malley1, Renuka Agrawal2, Kate E Grimm2, Jennifer Hummel2, Alexey Glazyrin3, Daniel C Dim4, Sheshadri Madhusudhana3, Lawrence M Weiss2.   

Abstract

BRAF V600E mutations have been reported in several histiocytic and dendritic cell neoplasms. In this case series, we report BRAF V600E-positive histiocytic and dendritic cell neoplasms in association with lymphomas and lymphoid proliferations. This is a review of cases with immunohistochemistry for BRAF V600E, with additional immunohistochemistry to categorize tumors. We report the first case of BRAF V600E-positive indeterminate cell tumor in association with angioimmunoblastic T-cell lymphoma. We also report a case of BRAF V600E-positive interdigitating dendritic cell sarcoma in a patient with positive B-cell polymerase chain reaction. It is unclear if these neoplasms developed as transdifferentiation of lymphoid neoplasms or if they developed independently. These cases illustrate the expanding spectrum of BRAF V600E-positive histiocytic and dendritic cell tumors and suggest that attention should be paid to lymphomas for possible coincident presentation of these disorders.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BRAF V600E; Indeterminate cell tumor; Interdigitating dendritic cell sarcoma; Langerhans cell histiocytosis

Mesh:

Substances:

Year:  2015        PMID: 25787243     DOI: 10.1016/j.anndiagpath.2015.02.008

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  16 in total

Review 1.  Braf mutation in interdigitating dendritic cell sarcoma: a case report and review of the literature.

Authors:  Elisabetta Di Liso; Natale Pennelli; Gigliola Lodovichetti; Cristina Ghiotto; Angelo Paolo Dei Tos; PierFranco Conte; Laura Bonanno
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 2.  Histiocytic neoplasms in the era of personalized genomic medicine.

Authors:  Benjamin H Durham; Eli L Diamond; Omar Abdel-Wahab
Journal:  Curr Opin Hematol       Date:  2016-07       Impact factor: 3.284

Review 3.  Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

Authors:  Jean-François Emile; Oussama Abla; Sylvie Fraitag; Annacarin Horne; Julien Haroche; Jean Donadieu; Luis Requena-Caballero; Michael B Jordan; Omar Abdel-Wahab; Carl E Allen; Frédéric Charlotte; Eli L Diamond; R Maarten Egeler; Alain Fischer; Juana Gil Herrera; Jan-Inge Henter; Filip Janku; Miriam Merad; Jennifer Picarsic; Carlos Rodriguez-Galindo; Barret J Rollins; Abdellatif Tazi; Robert Vassallo; Lawrence M Weiss
Journal:  Blood       Date:  2016-03-10       Impact factor: 22.113

4.  Special variant of histiocytosis.

Authors:  Koen D Quint; Arjen H Cleven; Maarten H Vermeer
Journal:  BMJ Case Rep       Date:  2017-10-25

5.  Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.

Authors:  Fabio Facchetti; Stefano Aldo Pileri; Luisa Lorenzi; Valentina Tabanelli; Lisa Rimsza; Stefania Pittaluga; Stephan Dirnhofer; Christiane Copie-Bergman; Laurence de Leval; Andreas Rosenwald; Andrew Wotherspoon; Falko Fend
Journal:  Virchows Arch       Date:  2017-07-10       Impact factor: 4.064

6.  Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling.

Authors:  Xuejun Tian; Jie Xu; Christopher Fletcher; Jason L Hornick; David M Dorfman
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

Review 7.  Interdigitating dendritic cell sarcoma: analysis of two original extra-nodal cases and review of literature.

Authors:  Jiayu Zhou; Qingling Li; Xiaodan Fu; Deyun Feng; Keda Yang; Junpu Wang
Journal:  Virchows Arch       Date:  2022-04-09       Impact factor: 4.064

Review 8.  Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma.

Authors:  Tang Liu; Jacson K Shen; Zhihong Li; Edwin Choy; Francis J Hornicek; Zhenfeng Duan
Journal:  Cancer Lett       Date:  2016-01-21       Impact factor: 8.679

Review 9.  MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age.

Authors:  Rikhia Chakraborty; Omar Abdel-Wahab; Benjamin H Durham
Journal:  Cold Spring Harb Perspect Med       Date:  2021-05-03       Impact factor: 6.915

10.  Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.

Authors:  Lucas R Massoth; Yin P Hung; Lawrence R Zukerberg; Erik A Williams; Judith A Ferry; Robert P Hasserjian; Valentina Nardi; G Petur Nielsen; Sam Sadigh; Vinayak Venkataraman; Martin Selig; Alison M Friedmann; Wesley Samore; Jonathan Keith Killian; Riza Milante; Joseph Giessinger; Kathleen Foley-Peres; Chelsea Marcus; Eric Severson; Daniel Duncan; Smruthy Sivakumar; Jeffrey S Ross; Vikram Desphande; Shakti H Ramkissoon; Jo-Anne Vergilio; Abner Louissaint
Journal:  Oncologist       Date:  2021-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.